Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sudeep Pharma Limited Call Transcript 2025

Dec 15, 2025

59914_rns_2025-12-15_b41ca68c-5e3c-46e2-a502-f8a9cac0ef27.pdf

Call Transcript

Open in viewer

Opens in your device viewer

Date: 15[th] December 2025

==> picture [152 x 86] intentionally omitted <==

To,

National Stock Exchange of India Limited BSE Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Bandra Kurla Dalal Street, Mumbai – 400001 Complex, Bandra (E), Mumbai – 400051 Scrip Code: 544619 Scrip Symbol- SUDEEPPHRM

Sub: Intimation of Earnings Call with Analysts/Investors on 22[nd] December 2025

Ref: Regulation 30 of the SEBI Listing Regulations, 2015

Dear Sir/Ma’am,

This is to inform that the “Earnings Call” of the Company with Analysts/Investors to discuss the operational & financial performance for the quarter and half year ended on September 30, 2025, is scheduled as below:

Day & Date: Monday, 22[nd] December 2025

Time: 11:30 a.m., IST

Registration Link and Access numbers: As per Annexure

Copy of Earnings Call invite is annexed herewith and is also hosted on our website https://www.sudeeppharma.com/.

Kindly take the same on record.

Thanking You.

For Sudeep Pharma Limited

DIMPLE Digitally signed by DIMPLEASHWINBHAI MEHTA DN: cn=DIMPLE ASHWINBHAI MEHTA, ASHWINBHAI c=IN, st=Gujarat, o=Personal, title=8748, serialNumber=be901a7b4cfd5ff4b6e3310 MEHTA 581e678582e8fcab3536586c4a365ba53eccbf1a6 Dimple Mehta Date: 2025.12.15 12:37:20 +05'30' Company Secretary & Compliance Officer M. No.: F13184

ENCL: A/a

CIN: U24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: [email protected]

==> picture [226 x 36] intentionally omitted <==

is pleased to invite you to the

Q2FY26 Results Conference Call

of

==> picture [144 x 52] intentionally omitted <==

Sudeep Pharma Limited

Represented by

Mr. Shanil Bhayani – Director Mr. Ketan Vyas – Chief Financial Officer

On

Monday, December 22, 2025 at 11:30 hrs India Time

Diamond Pass registration link: Copy this Link in your browser: Link

Call Co-ordinator:

Mr. Jaideep Goswami, Head of Equities: Email: [email protected] Mr. Sanjesh Jain: Phone: +91 22 6807 7153, e-mail: [email protected] Mr. Mohit Mishra: Phone: +91 22 6807 7637, e-mail: [email protected]

For any clarification, please contact:

Mr. Rushad Kapadia: Phone: +91 22 6807 7334, e-mail: [email protected] Ms. Seema Sehgal: Phone: +91 9871116926, e-mail: [email protected] Ms. Minali Ginwala: Phone: +91 22 6807 7454, e-mail: [email protected]